• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

How NLP Can Uncover Social Determinants of Heart Disease

by David Talby, CTO, John Snow Labs 03/23/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
NLP is Raising the Bar on Accurate Detection of Adverse Drug Events
David Talby, CTO, John Snow Labs

Heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. Cardiovascular disease-related deaths—which occur every 36 seconds—cost our country about $219 billion each year, according to the Centers for Disease Control and Prevention (CDC). People with poor cardiovascular health are also at increased risk of severe illness from COVID-19, so the time to act is now. There’s no time like the present to look at major risk factors—from obesity and smoking to high cholesterol and blood pressure—and how to avoid them. 

While acute care and medications exist to treat heart disease and other cardiovascular conditions, too often we look at how to manage ailments that already exist, rather than how to prevent them in the first place. While heart disease does affect a massive group of the population, like many diseases, it does discriminate, and without looking at the full spectrum of a patient’s life, it’s impossible to get to the root cause. In recent years, natural language processing (NLP) technology has been used to analyze social determinants of health to uncover helpfully, or potentially dangerous, information about patients that may help us understand more about the disease. 

Related: 8 Use Cases for Natural Language Processing (NLP) Technology in Healthcare

Social determinants are elements that directly impact a person’s health beyond diseases or drugs, such as access to healthy food, personal safety, housing, employment, literacy, family, employment, and personal freedom. These are often more important than clinical treatment when it comes to managing chronic diseases, like heart disease, and a slew of other medical conditions. The challenge here is that social determinants can often only be read from free-text notes in a healthcare setting—not in structured data. In order for medical professionals to realistically compile and use this information, they need NLP. 

Here’s why: doctors aren’t social workers, and in most cases, there’s no structured way to ask about social determinants. Without structured data, a lot of the pertinent information about social determinants will be in patient notes. Doctors will manually write about a patient’s social history, home environment, and similar types of health contributors. Structured data in electronic medical records (EMRs) would only consist of lab results, billing codes, and what medications the patient is taking. But if there’s substance abuse, unemployment, homelessness, or illiteracy, those will be in the notes. NLP is the automated way to connect the tissue between these disparate and siloed data sources to understand how these health events are related. 

In addition to the challenges of connecting free-text and structured data, sometimes, medical professionals simply don’t know what they’re looking for. Let’s say you want to do longer-form studies about what happens to patients with heart disease. Do their symptoms improve if they take vitamins and exercise regularly? They may—and if that’s what you’re looking to prove, that’s great. But NLP is the only viable way to correlate all potential variables—sleep, relationships, safety, employment, obesity, etc.—to get real answers. It would be impractically time-consuming to read line-by-line and try to connect the dots, even if all the information you needed was in the text. But what if you need to consider diagnostic imaging reports, or social media behavior, too? You need software to contract the relationship between these things.

There are also questions about the quality of data. Fortunately, cardiology is well-known for using data-centric governance models. The American College of Cardiology cardiac catheterization and angioplasty initiated its data registry in 1994. That was a preliminary step after which the CathPCI registry of the National Cardiovascular Data Registry (NCDR) started its duties 25 years later, taking the charge of 90% of cardiac-related data in the US. This regulatory body governs the quality enhancement process with regard to the procedures and outcomes in many healthcare organizations. Quality data is critical for providing accurate analytics. 

Despite this, data integration is still a problem in large research projects where information is collected from different entry points and data is available in different formats, and some are missing, or inaccurate. Once again, NLP is an excellent source for researchers working in the cardiology field to mitigate this issue. With existing datasets in this specialty, researchers and data scientists can more easily glean insights or uncover new findings with increased accuracy. Having curated and standardized data can make researchers’ jobs much easier and save years of headaches.

Social determinants are a huge part of public health and are often undercounted when exploring chronic illnesses, like heart disease. A woman who is dealing with domestic abuse at home isn’t going to be prioritizing her diet and exercise regimen to manage her heart health. A man who is unemployed and lost his health insurance may start missing important follow-up appointments in order to defray costs. Being aware of these social indicators and using them to inform care—whether prevention or management of heart disease and other illnesses—is vital for patients’ overall health outcomes. Technology like NLP has made it easier to start correlating social determinants to heart health and has the potential to vastly improve prevention and treatment if applied correctly and ethically.


About David Talby

David Talby, Ph.D., MBA, is the CTO of John Snow Labs. He has spent his career making AI, big data, and data science solve real-world problems in healthcare, life science, and related fields. John Snow Labs is an award-winning AI and NLP company, accelerating progress in data science by providing state-of-the-art models, data, and platforms. Founded in 2015, it helps healthcare and life science companies build, deploy, and operate AI products and services.


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Acute Care, AI, behavior, big data, Blood Pressure, Coronavirus (COVID-19), Data Integration, Diagnostic Imaging, Electronic Medical Records, health insurance, Heart, heart disease, medical records, Natrual Language Processing, NLP, Obesity, Public Health, risk, Social Determinants of Health, Social Media, Substance Abuse, technology in healthcare, Vital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |